The cost of insulin has been a major policy issue in recent years. FDA Commissioner Scott Gottlieb, MD, said the approval of a new choice in insulin was a sign of his commitment to giving patients ...
Pending any patent issues that have yet to be resolved by the Company, the FDA has concluded that the product has met all necessary regulatory requirements for approval. The Food and Drug ...
PARIS, Dec. 11, 2017 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has approved Sanofi's Admelog ®, the first follow-on insulin lispro to help people living with diabetes manage blood ...
With an FDA nod for its copycat of Eli Lilly's popular Humalog insulin, Sanofi is one step closer to challenging blockbuster diabetes sales from its rival. Sanofi's Admelog is the first meal-time ...
The US Food and Drug Administration has cleared Sanofi's Admelog, the first follow-on biologic version of Eli Lilly’s Humalog, to manage mealtime blood sugar levels in people with diabetes. The US ...
Admelog (insulin lispro injection) 100 Units/mL will be available in U.S. in vial and SoloStar pen Paris, France - December 11, 2017 - The U.S. Food and Drug Administration (FDA) has approved Sanofi's ...
Admelog (insulin lispro injection) 100 Units/mL will be available in U.S. in vial and SoloStar pen Paris, France - December 11, 2017 - The U.S. Food and Drug Administration (FDA) has approved Sanofi`s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results